AKMU’s Lee Su-hyun dismisses rumors of using weight-loss drug Wegovy
Lee Su-hyun of duo AKMU denies rumors of using weight-loss drug Wegovy. Courtesy of YG Entertainment
Lee Su-hyun of sibling duo AKMU has dismissed speculation that she used the obesity treatment drug Wegovy to lose weight, stressing that her slimmer figure is the result of disciplined daily habits.
Lee addressed the rumors on her social media. “I didn’t do Wegovy. It’s really unfair. I’ve been holding back on malatang and tteokbokki, working out hard and fighting myself every day to build healthy habits — it feels so unfair.” She added, “I’m managing myself the proper way for a sustainable and healthy life.”
Her comments came after fans noticed her noticeably slimmer physique during AKMU’s ongoing standing concert series “Akdong,” fueling speculation that she had turned to the weight-loss injection. Lee’s post served as a direct rebuttal to those rumors.
Lee has previously shared details of her strict routine. Appearing on YouTube channel “Jung Yong-hwa’s LP Room” in May, she revealed that she and her brother Lee Chan-hyuk had started living together again. “At 11 a.m., we read the Bible, then I work out with a trainer and eat a healthy meal. In the afternoon, we each take lessons and live in a structured way,” she said.
The singer also reassured fans concerned about her health. When one fan commented, “How much weight have you lost? Whatever happens, your health comes first,” Lee replied, “Thank you. I’m the healthiest I’ve ever been.”
She has also shared snapshots of her meals, including brown rice, chicken breast sausage and kimchi, to emphasize her focus on balanced eating.
Since debuting in 2012, AKMU has released a string of hits including “200%,” “Give Love,” “Last Goodbye,” “How Can I Love the Heartbreak, You’re the One I Love” and “Love Lee.”
The duo will continue their “Akdong” concert run from Friday to Sunday at Myunghwa Live Hall in Yeongdeungpo, Seoul.
This article from the Hankook Ilbo, the sister publication of The Korea Times, is translated by a generative AI and edited by The Korea Times.